- Using Tesla Math, GM’s Buick Unit Should Be Worth $1.1 Trillion
- No, Tesla Does Not Outsell the Mercedes S-Class in the U.S. or Globally
- GM's Triple Assault on Tesla -- Including a Range-Topping Cadillac Plug-In
- The 10 Most 'Socialist' States in America
- TheStreet Seeks Retraction From Washington Post on Steven Pearlstein Column
The revenue number and outlook are what investors will be most concerned with.
The stock is being accumulated as a solid base takes shape. A breakout could be in the works.
Traders are selling the stock after-hours on news of soft sales and in-line guidance.
A number of stocks are not yet extended, even after Tuesday's big gains.
Analysts are looking for earnings of $0.91 a share on sales of $290.7 million.
Jazz Pharmaceuticals' stock surges on an analyst's note, and sales of its key drug are growing.
Some yellow flags are signaling caution, but bullish charts still dominate the growth screens.
The convenience store company spurned buyout offers and is focused on growth -- and it's paying off.
Despite the broadly positive day, there was a lot of downright crummy price action. But these two stocks are setting up nicely.
Recent price and volume trends have been solid.